Public filings / MDGL on Yahoo Finance (opens in a new tab)
MDGL: insider buying, 13F holders, analyst moves
Madrigal Pharmaceuticals Inc
A summary of public filings about Madrigal Pharmaceuticals Inc. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
5 of our 100 managers hold MDGL
Combined reported value $3.25B; 1 sold out since Q1 2026.
Holders among our 100 managers: 7 in Q3 2023, 5 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Baker Bros. Advisors | $1.15B | 5.77% | Unchanged |
| RTW Investments | $1.07B | 9.14% | Unchanged |
| Avoro Capital Advisors | $984.4M | 8.84% | Added |
| Alkeon Capital | $43.0M | 0.17% | Unchanged |
| Tudor Investment | $6.2M | 0.03% | Trimmed |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.